Dr. Hill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
# Taussig
Cleveland, OH 44195Phone+1 216-445-9451
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of ChicagoResidency, Internal Medicine, 2005 - 2008
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2005
- State University of New YorkPh.D., Genetics, 2003
- Dartmouth CollegeB.A., Biophysical Chemistry, Cum Laude, 1996
Certifications & Licensure
- OH State Medical License 2008 - 2026
- IL State Medical License 2005 - 2008
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Elden Bennett Hartshorn Medal Dartmouth College, 1996
- Presidential Scholar Dartmouth College, 1995
- Join now to see all
Clinical Trials
- Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma Start of enrollment: 2008 Jun 01
- Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Start of enrollment: 2014 Mar 01
- Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma Start of enrollment: 2015 Jan 28
- Join now to see all
Publications & Presentations
PubMed
- 53 citationsOutcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.Anthony R. Mato, Lindsey E. Roeker, John N. Allan, John M. Pagel, Danielle M. Brander
American Journal of Hematology. 2018-11-01 - 22 citationsHuman N-Myristoyltransferases Form Stable Complexes with Lentiviral Nef and Other Viral and Cellular Substrate ProteinsBrian T. Hill, Jacek Skowronski
Journal of Virology. 2005-01-15 - 935 citationsKTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell LymphomaMichael Wang, Javier Munoz, Andre Goy, Frederick L. Locke, Caron A. Jacobson
The New England Journal of Medicine. 2020-04-01
Journal Articles
- Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell TransplantationDeepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
- Flow Cytometric Analysis of Cerebrospinal Fluid is Low Diagnostic Yield in Samples Without Atypical Morphology or Prior History of Hematologic MalignancyCollie AMB, Hill BT, Stevens GHJ, Fenner K, Gazdick E, His ED, Am J. Clin. Path., 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes AnalysisBrian T. Hill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...Brian T. Hill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T ConsortiumBrian T. Hill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Maintenance After Frontline Therapy in Follicular Lymphoma? An Appropriate Management Plan for...ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
- Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Clinical Challenges: Complications of CLLDecember 13th, 2021
- Don’t Miss These Cleveland Clinic Cancer Center Presentations at the 2019 ASCO Annual MeetingMay 30th, 2019
- New Treatment Regimen Holds Promise for Patients with Mantle Cell LymphomaJanuary 28th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: